The deal range was $2.85-$2.95. Leerink, Stifel and Guggenheim acted as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XFOR:
- X4 Pharmaceuticals announces common stock offering, no amount given
- Altimmune appoints Christophe Arbet-Engels as CMO
- X4 Pharmaceuticals Announces Major Strategic Restructuring
- X4 Pharmaceuticals announces restructuring, 50% reduction in workforce
- X4 Pharmaceuticals files to sell 59.89M shares of common stock for holders